Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Long Term Debt (2020 - 2023)

MDxHealth (MDXH) has disclosed Total Long Term Debt for 4 consecutive years, with $39.1 million as the latest value for Q4 2023.

  • Quarterly Total Long Term Debt rose 2.99% to $39.1 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $39.1 million through Dec 2023, up 2.99% year-over-year, with the annual reading at $39.1 million for FY2023, 2.99% up from the prior year.
  • Total Long Term Debt hit $39.1 million in Q4 2023 for MDxHealth, up from $38.0 million in the prior quarter.
  • In the past five years, Total Long Term Debt ranged from a high of $39.1 million in Q4 2023 to a low of $10.3 million in Q4 2021.
  • Historically, Total Long Term Debt has averaged $24.9 million across 4 years, with a median of $25.2 million in 2020.
  • Biggest five-year swings in Total Long Term Debt: dropped 16.44% in 2021 and later skyrocketed 269.88% in 2022.
  • Year by year, Total Long Term Debt stood at $12.3 million in 2020, then fell by 16.44% to $10.3 million in 2021, then surged by 269.88% to $38.0 million in 2022, then grew by 2.99% to $39.1 million in 2023.
  • Business Quant data shows Total Long Term Debt for MDXH at $39.1 million in Q4 2023, $38.0 million in Q4 2022, and $10.3 million in Q4 2021.